Endocrinology, Reproduction and Neuroendocrine Regulation
Hormone classes and receptors, hypothalamic-pituitary axes, thyroid, adrenal, pancreas, calcium control, male and female reproduction, pregnancy and lactation.
- 21 min
On this page · 13 sections
Prerequisites
- Membranes, Transport and Electrical Properties — membrane receptors and ion channels used by peptide hormones.
- Regulation of Gene Expression and Epigenetics — nuclear receptors are ligand-activated transcription factors.
- Digestion, Energy Balance, BMR, Thermoregulation and Stress — the HPA axis and gut hormones introduced there are completed here.
The Hook: A Stalk Cut in Two
How CSIR NET asks it. Part B: hormone–receptor–second-messenger pairs, sources of hypothalamic and pituitary hormones, steroidogenic enzymes, thyroid hormone synthesis steps, calcium regulators, phases of the menstrual cycle, cell types of the testis, placental hormones. Part C: feedback-loop lesion data (which hormone rises and which falls), hormone profiles across the cycle, binding data (Scatchard), knockout and ablation experiments, insect molting hormone experiments.
Hormones and Their Receptors
| Class | Examples | Solubility and transport | Receptor | Storage |
|---|---|---|---|---|
| Peptides / proteins | Insulin, glucagon, GH, ACTH, ADH, oxytocin | Water-soluble; free in plasma; short half-life | Cell surface | Stored in secretory granules |
| Steroids | Cortisol, aldosterone, testosterone, estradiol, progesterone, calcitriol | Lipid-soluble; bound to carrier proteins (SHBG, CBG, albumin) | Intracellular (nuclear) receptors | Made on demand, not stored |
| Amines: catecholamines | Adrenaline, noradrenaline, dopamine | Water-soluble | Cell surface (GPCRs) | Vesicles |
| Amines: thyroid hormones | T₄, T₃ | Lipid-soluble; bound to TBG, transthyretin, albumin | Nuclear receptor (TR) | Stored as thyroglobulin in colloid |
| Eicosanoids | Prostaglandins, thromboxanes | Local | GPCRs | Made on demand |
| Receptor / pathway | Hormones (examples) |
|---|---|
| GPCR → Gs → cAMP ↑ | Glucagon, ACTH, TSH, LH, FSH, hCG, PTH, calcitonin, ADH (V₂), CRH, GHRH, β-adrenergic |
| GPCR → Gq → IP₃/DAG/Ca²⁺ | TRH, GnRH, ADH (V₁), oxytocin, angiotensin II (AT₁), α₁-adrenergic, gastrin |
| GPCR → Gi → cAMP ↓ | Somatostatin, α₂-adrenergic, dopamine D₂ (on lactotrophs) |
| Receptor tyrosine kinase | Insulin, IGF-1 |
| Cytokine receptor + JAK–STAT | GH, prolactin, leptin, EPO |
| Receptor guanylyl cyclase → cGMP | ANP, BNP |
| Nuclear receptors | Cortisol (GR), aldosterone (MR), sex steroids (AR, ER, PR), T₃ (TR), calcitriol (VDR), retinoids |
Steroid receptor action: hormone diffuses in → binds receptor (glucocorticoid receptor is cytoplasmic with chaperones such as Hsp90 until ligand binds) → dimer enters nucleus → binds hormone response elements → recruits coactivators → transcription changes over hours. Thyroid hormone receptors sit on DNA (often as heterodimers with RXR) even without hormone, repressing until T₃ binds.
Feedback. Most axes use negative feedback: long loop (target-gland hormone → hypothalamus and pituitary), short loop (pituitary hormone → hypothalamus) and ultrashort loop. The main positive feedback examples: the mid-cycle LH surge (estradiol), oxytocin during labour (Ferguson reflex).
Neuroendocrine Regulation: Hypothalamus and Pituitary
graph TD
HY["Hypothalamus
(parvocellular neurons)"] -- "releasing/inhibiting hormones
via median eminence and
hypophyseal portal veins" --> AP["Anterior pituitary
(adenohypophysis, from Rathke's pouch)"]
MAG["Supraoptic and paraventricular
magnocellular neurons"] -- "axons (hypothalamo-
hypophyseal tract)" --> PP["Posterior pituitary
(neurohypophysis, neural tissue)"]
AP --> GH["GH"]
AP --> PRL["Prolactin"]
AP --> TSH["TSH"]
AP --> ACTH["ACTH"]
AP --> GN["LH, FSH"]
PP --> ADH["ADH (vasopressin)"]
PP --> OXT["Oxytocin"]| Hypothalamic hormone | Effect on anterior pituitary |
|---|---|
| TRH | ↑ TSH (and prolactin) |
| CRH | ↑ ACTH (with vasopressin) |
| GnRH (pulsatile) | ↑ LH and FSH |
| GHRH | ↑ GH |
| Somatostatin (GHIH) | ↓ GH (and TSH) |
| Dopamine (PIH) | ↓ Prolactin (tonic inhibition) |
- Neurosecretion: hypothalamic neurons release hormones into blood instead of onto another cell. ADH and oxytocin are made in magnocellular cell bodies as larger precursors (with their carrier neurophysins), transported down axons and released from the posterior pituitary.
- GnRH must be pulsatile. Continuous GnRH (or long-acting agonists) down-regulates gonadotroph receptors and suppresses LH and FSH, which is used therapeutically (prostate cancer, precocious puberty, IVF protocols).
- Neuroendocrine reflexes: suckling → oxytocin (milk ejection) and prolactin (milk synthesis, via reduced dopamine); stretch of cervix → oxytocin (Ferguson reflex); osmotic stimuli → ADH.
Pineal gland and circadian control
Light → retinal ganglion cells containing melanopsin → retinohypothalamic tract → suprachiasmatic nucleus (master clock) → paraventricular nucleus → spinal intermediolateral column → superior cervical ganglion → pineal. At night noradrenaline acts on β₁ receptors → cAMP → arylalkylamine N-acetyltransferase (the rate-limiting step from serotonin) → melatonin. Melatonin is high in darkness, signals night length (photoperiod) and controls seasonal breeding in many mammals.
Neuroendocrine control in invertebrates
| Animal | Brain signal | Gland and hormone | Result |
|---|---|---|---|
| Insects | PTTH (prothoracicotropic hormone) from brain neurosecretory cells | Prothoracic glands → ecdysone (converted to active 20-hydroxyecdysone in tissues) | Triggers each moult |
| Brain controls | Corpora allata → juvenile hormone (JH) | Sets the type of moult | |
| Crustaceans | X-organ–sinus gland in the eyestalk releases moult-inhibiting hormone | Y-organ → ecdysteroids | Removing the eyestalks removes the inhibition and triggers moulting |
JH rule for insects: ecdysone with high JH → larval moult; ecdysone with low JH → pupal moult (metamorphosis in holometabolous insects); ecdysone without JH → adult. Removing the corpora allata from a young larva gives a precocious, miniature pupa or adult; implanting extra corpora allata into a last-instar larva gives an extra larval instar (classic Wigglesworth-type experiments).
The Endocrine Glands
Growth hormone
GH (somatotrophs) is released in pulses, mostly during deep sleep; stimulated by GHRH, ghrelin, hypoglycaemia, amino acids and exercise; inhibited by somatostatin, IGF-1 and hyperglycaemia.
- Indirect (growth) actions via IGF-1 from the liver (and locally): bone and cartilage growth, protein synthesis.
- Direct metabolic actions: lipolysis, reduced glucose uptake (diabetogenic, anti-insulin), protein anabolism.
- Excess before epiphyseal closure → gigantism; after → acromegaly. Deficiency → proportionate dwarfism. Laron syndrome: GH receptor defect → high GH, low IGF-1, short stature.
Thyroid
graph LR
I["Iodide in blood"] -- "NIS (2 Na+ : 1 I-)
basolateral" --> F["Follicular cell"]
F -- "pendrin (apical)" --> C["Colloid"]
C -- "TPO + H2O2:
oxidation, organification
(iodinate Tyr of thyroglobulin)" --> MD["MIT, DIT on thyroglobulin"]
MD -- "TPO: coupling" --> T["T4 (DIT+DIT), T3 (MIT+DIT)"]
T -- "endocytosis, lysosomal
proteolysis (TSH-stimulated)" --> B["Secretion: mostly T4,
some T3"]- Thyroid peroxidase (TPO) catalyses oxidation, organification and coupling; blocked by propylthiouracil and methimazole. Large iodide doses briefly inhibit organification (Wolff–Chaikoff effect).
- T₄ is the main secreted form; T₃ is the active form. Peripheral deiodinases: D1 and D2 convert T₄ → T₃ (activation); D3 makes inactive reverse T₃.
- Actions: ↑ BMR and O₂ consumption (more Na⁺/K⁺-ATPase, mitochondria), thermogenesis, ↑ β-adrenergic receptor expression (tachycardia), essential for brain development and growth (congenital hypothyroidism → cretinism), and for amphibian metamorphosis.
- Graves’ disease: antibodies stimulate the TSH receptor → hyperthyroidism, goitre, low TSH. Hashimoto’s thyroiditis: autoimmune destruction (anti-TPO) → hypothyroidism, high TSH. Iodine deficiency → low T₄ → high TSH → goitre.
| Pattern | TSH | Free T₄ | Site |
|---|---|---|---|
| Primary hypothyroidism | High | Low | Thyroid |
| Secondary (pituitary) hypothyroidism | Low or inappropriately normal | Low | Pituitary |
| Primary hyperthyroidism (Graves) | Low | High | Thyroid |
| TSH-secreting pituitary tumour | High | High | Pituitary |
Calcium and phosphate
Plasma Ca²⁺ is held within a narrow range (total about 2.5 mM, roughly half ionised). Ionised Ca²⁺ is sensed by the calcium-sensing receptor (a GPCR) on parathyroid chief cells.
| Hormone | Source | Bone | Kidney | Gut | Net |
|---|---|---|---|---|---|
| PTH | Parathyroid chief cells; secreted when Ca²⁺ falls | ↑ Resorption (indirectly: osteoblasts express RANKL → osteoclasts) | ↑ Ca²⁺ reabsorption (DCT); ↓ phosphate reabsorption (PCT); ↑ 1α-hydroxylase | Indirect via calcitriol | Ca²⁺ ↑, phosphate ↓ |
| Calcitriol (1,25-(OH)₂D₃) | Skin (UVB: 7-dehydrocholesterol → D₃) → liver 25-hydroxylation → kidney 1α-hydroxylation | Mineralisation (and resorption at high levels) | ↑ Ca²⁺ and phosphate reabsorption | ↑ Ca²⁺ and phosphate absorption | Ca²⁺ ↑, phosphate ↑ |
| Calcitonin | Thyroid parafollicular C cells; secreted when Ca²⁺ rises | ↓ Osteoclast activity | ↑ Ca²⁺ excretion | — | Ca²⁺ ↓ (minor role in adult humans) |
| FGF23 | Osteocytes; secreted when phosphate or calcitriol rise | — | ↓ Phosphate reabsorption; ↓ 1α-hydroxylase (needs co-receptor Klotho) | — | Phosphate ↓ |
Vitamin D deficiency → rickets (children) or osteomalacia (adults). Hypocalcaemia raises nerve excitability (tetany).
Adrenal cortex and steroidogenesis
| Zone | Main product | Control |
|---|---|---|
| Zona glomerulosa | Aldosterone (mineralocorticoid) | Angiotensin II, plasma K⁺ (ACTH minor) |
| Zona fasciculata | Cortisol (glucocorticoid) | ACTH |
| Zona reticularis | Adrenal androgens (DHEA, DHEA-S) | ACTH |
graph TD
CH["Cholesterol"] -- "StAR (into mitochondria),
CYP11A1 side-chain cleavage" --> PREG["Pregnenolone"]
PREG -- "3-beta-HSD" --> PROG["Progesterone"]
PREG -- "CYP17 17-alpha-hydroxylase" --> OHPREG["17-OH-pregnenolone"]
PROG -- "CYP21 (21-hydroxylase)" --> DOC["11-Deoxycorticosterone"]
DOC -- "CYP11B1 / CYP11B2" --> ALDO["Corticosterone to aldosterone
(aldosterone synthase, glomerulosa)"]
PROG -- "CYP17" --> OHP["17-OH-progesterone"]
OHP -- "CYP21" --> DOX["11-Deoxycortisol"]
DOX -- "CYP11B1 (11-beta-hydroxylase)" --> CORT["Cortisol"]
OHPREG -- "CYP17 17,20-lyase" --> DHEA["Androgens: DHEA, androstenedione,
testosterone"]
DHEA -- "aromatase (CYP19)" --> E2["Estradiol"]
DHEA -- "5-alpha-reductase" --> DHT["Dihydrotestosterone"]- StAR-mediated cholesterol transport into mitochondria is the acute rate-limiting step.
- 21-hydroxylase deficiency (the commonest form of congenital adrenal hyperplasia): cortisol and aldosterone fall; ACTH rises; precursors are shunted to androgens → virilisation of female infants, salt wasting; 17-OH-progesterone is high (diagnostic marker).
- Addison’s disease (primary adrenal insufficiency): low cortisol and aldosterone, high ACTH → hyperpigmentation (POMC also yields MSH), hyponatraemia, hyperkalaemia. Cushing’s syndrome: cortisol excess (central obesity, hyperglycaemia, thin skin, hypertension). Conn’s syndrome: primary aldosterone excess → hypertension, hypokalaemia, low renin.
- Dexamethasone suppression test: in a pituitary (ACTH-dependent) source, high-dose dexamethasone suppresses cortisol; in an adrenal tumour or ectopic ACTH, it does not.
Adrenal medulla
Chromaffin cells (modified postganglionic sympathetic neurons): tyrosine → L-DOPA (tyrosine hydroxylase, rate-limiting) → dopamine (aromatic L-amino acid decarboxylase) → noradrenaline (dopamine β-hydroxylase, inside vesicles) → adrenaline (PNMT, cytosolic, induced by cortisol). Degraded by MAO and COMT (urinary vanillylmandelic acid). Phaeochromocytoma: episodic hypertension, headache, sweating.
| Receptor | G protein | Typical sites and effects |
|---|---|---|
| α₁ | Gq | Vascular smooth muscle (constriction), pupil dilator |
| α₂ | Gi | Presynaptic (reduce NA release), pancreatic β cells (↓ insulin) |
| β₁ | Gs | Heart (rate, force), juxtaglomerular cells (renin) |
| β₂ | Gs | Bronchial and some vascular smooth muscle (relaxation), liver, skeletal muscle |
| β₃ | Gs | Adipose tissue (lipolysis, brown-fat thermogenesis) |
Endocrine pancreas
Islets of Langerhans: β cells (insulin, also amylin), α cells (glucagon), δ cells (somatostatin), PP cells (pancreatic polypeptide), ε cells (ghrelin).
Glucose-stimulated insulin secretion:
graph TD
G["Blood glucose rises"] --> T["Glucose enters beta cell
(GLUT transporter)"]
T --> GK["Glucokinase phosphorylates
(the glucose sensor)"]
GK --> ATP["Glycolysis + oxidation:
ATP/ADP ratio rises"]
ATP --> K["KATP channels close
(Kir6.2 + SUR1)"]
K --> DEP["Depolarisation"]
DEP --> CA["Voltage-gated Ca2+ channels open"]
CA --> EXO["Insulin granule exocytosis"]
INC["GLP-1, GIP (Gs, cAMP)"] -. "amplify" .-> EXO- Sulfonylureas close K_ATP (bind SUR1) → insulin release; diazoxide opens it. Activating mutations in K_ATP subunits cause neonatal diabetes; inactivating mutations cause congenital hyperinsulinism.
- Proinsulin → insulin + C-peptide (equimolar); C-peptide measures endogenous secretion even in patients injecting insulin.
- Insulin signalling: receptor tyrosine kinase → IRS → PI3K → Akt → GLUT4 translocation (muscle, adipose), glycogen synthesis (GSK3 inhibition), protein synthesis (mTORC1), lipogenesis; inhibits lipolysis, gluconeogenesis and ketogenesis. The Ras–MAPK branch mediates growth effects.
- Glucagon (Gs → cAMP → PKA) acts mainly on liver: glycogenolysis, gluconeogenesis, ketogenesis. Muscle has no glucagon receptors.
- The incretin effect: oral glucose releases more insulin than the same plasma glucose achieved intravenously, because GIP and GLP-1 amplify secretion. Diabetes types are compared on the interorgan page.
Other endocrine organs
Kidney (renin, EPO, calcitriol), heart (ANP, BNP), adipose tissue (leptin, adiponectin), liver (IGF-1, angiotensinogen, hepcidin, FGF21), thymus (thymic peptides for T-cell maturation), gut (many hormones; previous page).
Reproduction
Male reproductive physiology
| Cell | Location | Hormone input | Functions |
|---|---|---|---|
| Leydig cells | Interstitium, between tubules | LH | Testosterone |
| Sertoli cells | Seminiferous tubule wall | FSH and testosterone | Nurse germ cells; tight junctions form the blood–testis barrier; secrete androgen-binding protein, inhibin B (feedback on FSH), fluid; in the fetus secrete anti-Müllerian hormone |
Spermatogenesis: spermatogonia (mitosis; stem cells at the basement membrane) → primary spermatocytes (meiosis I) → secondary spermatocytes (meiosis II) → spermatids → spermiogenesis (acrosome from Golgi, condensed nucleus with protamines replacing histones, flagellum, loss of cytoplasm as the residual body) → spermatozoa. The full process takes a little over two months in humans. Sperm mature in the epididymis (motility) and undergo capacitation in the female tract (cholesterol efflux from the membrane, hyperactivated motility), followed by the acrosome reaction at the zona pellucida.
Androgens: testosterone acts directly (Wolffian ducts, muscle, spermatogenesis, libido) and through dihydrotestosterone (5α-reductase: external genitalia, prostate, male-pattern hair) and estradiol (aromatase: bone maturation, epiphyseal closure, feedback in the brain).
Feedback: testosterone (directly and as estradiol) suppresses GnRH and LH; inhibin B selectively suppresses FSH.
Female reproductive physiology
Oogenesis: oogonia multiply only before birth; primary oocytes enter meiosis I in fetal life and arrest in prophase I (diplotene, dictyate stage) for years. Before ovulation, the LH surge restarts meiosis I → secondary oocyte + first polar body, which then arrests at metaphase II until fertilisation; completion of meiosis II gives the second polar body. Germ-cell numbers peak in mid-gestation and then fall by atresia throughout life; only a few hundred oocytes are ever ovulated.
Two-cell, two-gonadotropin model: LH stimulates theca cells to make androgens (androstenedione); these diffuse to granulosa cells, where FSH-induced aromatase converts them to estradiol.
graph TD
F1["Follicular phase:
FSH recruits follicles;
dominant follicle makes estradiol"] --> F2["Rising estradiol:
negative feedback switches
to POSITIVE feedback"]
F2 --> S["LH surge (and smaller FSH surge)
mid-cycle"]
S --> O["Ovulation; meiosis I completes;
oocyte arrests at metaphase II"]
O --> L["Luteal phase: corpus luteum makes
progesterone + estradiol + inhibin A
(negative feedback)"]
L --> N{"Pregnancy?"}
N -- "No" --> R["Luteolysis, hormones fall,
menstruation, FSH rises again"]
N -- "Yes" --> H["hCG from trophoblast
rescues corpus luteum"]
R --> F1| Cycle phase (28-day human cycle) | Ovary | Uterus | Dominant hormone |
|---|---|---|---|
| Days 1–5 | Early follicular | Menstrual (shedding of functional layer) | Low E₂, P; FSH rising |
| Days 6–14 | Late follicular | Proliferative | Estradiol (endometrium regrows, cervical mucus thin and stretchy) |
| About day 14 | Ovulation | — | LH surge |
| Days 15–28 | Luteal | Secretory (glands secrete, stroma oedematous) | Progesterone (thick mucus, basal body temperature rises by a few tenths of a degree) |
The luteal phase is the more constant length (about 14 days); variation in cycle length is mostly in the follicular phase. Estrous cycles of other mammals differ: no menstruation (the endometrium is resorbed), and sexual receptivity is restricted to estrus. Induced (reflex) ovulators such as rabbits, cats and camelids ovulate only after copulation triggers the LH surge; humans, rats and cattle are spontaneous ovulators.
Fertilisation, pregnancy and placental hormones
- Fertilisation: sperm bind zona pellucida glycoproteins → acrosome reaction → fusion → the oocyte’s cortical reaction (cortical granule exocytosis modifies the zona) blocks polyspermy; Ca²⁺ waves activate the egg (see Basic Concepts of Development).
- Implantation of the blastocyst occurs about a week after fertilisation.
- hCG from the syncytiotrophoblast acts on the LH receptor to keep the corpus luteum secreting progesterone in early pregnancy; it is the hormone detected by pregnancy tests. From roughly the second month (often dated to weeks 7–10) the placenta produces enough progesterone itself (the luteal–placental shift), so the corpus luteum is no longer essential.
| Placental hormone | Role |
|---|---|
| hCG | Rescues corpus luteum; in a male fetus stimulates fetal Leydig cells |
| Progesterone | Keeps endometrium (decidua) and suppresses myometrial contraction |
| Estrogens (mainly estriol) | Uterine and breast growth; estriol needs the fetoplacental unit (fetal adrenal DHEA-S → fetal liver 16-hydroxylation → placental aromatase) |
| Human placental lactogen (chorionic somatomammotropin) | Anti-insulin, raises maternal glucose and fatty acids for the fetus |
| Relaxin (also corpus luteum) | Softens pubic ligaments and cervix |
Parturition: rising estrogen-to-progesterone influence increases oxytocin receptors and gap junctions in the myometrium; prostaglandins and oxytocin drive contractions; cervical stretch → more oxytocin (Ferguson reflex, positive feedback) until delivery.
Lactation: during pregnancy estrogen, progesterone, prolactin and hPL develop the breast, but high estrogen and progesterone block milk production. After delivery they fall, and prolactin (released by suckling) drives milk synthesis; oxytocin contracts myoepithelial cells for milk ejection. Suckling also suppresses GnRH pulses (lactational amenorrhoea).
Sex determination and differentiation in brief
SRY on the Y chromosome → bipotential gonad becomes a testis (SOX9 in Sertoli cells). Sertoli cells’ AMH regresses the Müllerian ducts; Leydig testosterone maintains the Wolffian ducts; DHT masculinises external genitalia. Without SRY: ovary, Müllerian ducts persist, Wolffian ducts regress.
| Condition | Karyotype | Key defect | Phenotype |
|---|---|---|---|
| Complete androgen insensitivity | 46,XY | Androgen receptor | Female external genitalia, testes present, no uterus (AMH works), no Wolffian derivatives |
| 5α-reductase deficiency | 46,XY | No DHT | Ambiguous genitalia at birth; virilisation at puberty |
| Congenital adrenal hyperplasia (21-OH) | 46,XX | Cortisol pathway | Virilised external genitalia; internal female organs normal |
| Turner syndrome | 45,X | Monosomy X | Streak gonads, short stature |
| Klinefelter syndrome | 47,XXY | Extra X | Small testes, infertility, high FSH and LH |
Memory Tricks
Don’t Confuse
| This | vs | That |
|---|---|---|
| Anterior pituitary: glandular, portal-blood control | vs | Posterior pituitary: neural, releases hypothalamic ADH and oxytocin |
| Prolactin: tonically inhibited by dopamine | vs | Other anterior pituitary hormones: mainly stimulated |
| Pulsatile GnRH: stimulates LH/FSH | vs | Continuous GnRH: suppresses them |
| T₄: main secreted form | vs | T₃: active form; rT₃ inactive |
| Graves: stimulating TSH-receptor antibodies, low TSH | vs | Hashimoto: destructive, high TSH |
| PTH: Ca²⁺ up, phosphate down | vs | Calcitriol: Ca²⁺ up, phosphate up |
| Primary adrenal failure (Addison): high ACTH, pigmentation | vs | Secondary (pituitary) failure: low ACTH, no pigmentation, aldosterone largely preserved |
| Leydig cells: LH, testosterone | vs | Sertoli cells: FSH, inhibin B, ABP, AMH, barrier |
| Theca cells: LH → androgens | vs | Granulosa cells: FSH → aromatase → estradiol |
| Primary oocyte: arrested prophase I | vs | Secondary oocyte: arrested metaphase II |
| Prolactin: milk synthesis | vs | Oxytocin: milk ejection |
Common Mistakes
Practice
All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.
Level 1: Foundation
- Which enzyme catalyses iodination of thyroglobulin?
- Which cell type in the testis secretes inhibin B?
- Which gland produces juvenile hormone in insects?
Answers
- Thyroid peroxidase (TPO).
- Sertoli cells.
- Corpora allata.
Level 2: Part B Style
Q1 (practice). After surgical section of the pituitary stalk, which plasma hormone level is expected to rise?
- (a) ACTH
- (b) TSH
- (c) Prolactin
- (d) LH
Answer and explanation
(c) Prolactin. Dopamine from the hypothalamus tonically inhibits lactotrophs; cutting the portal connection removes this inhibition. The other hormones lose their releasing hormones and fall.
Q2 (practice). A patient has high plasma TSH and low free T₄. Which is the most likely diagnosis?
- (a) Graves’ disease
- (b) Hashimoto’s thyroiditis
- (c) Pituitary failure
- (d) TSH-secreting adenoma
Answer and explanation
(b). Low T₄ with high TSH means the thyroid is failing and the pituitary is responding normally (primary hypothyroidism). Graves gives low TSH and high T₄; pituitary failure gives low or normal TSH with low T₄; a TSH adenoma gives high TSH and high T₄.
Q3 (practice). A newborn with 46,XX karyotype has virilised external genitalia, low plasma sodium, high potassium and markedly raised 17-hydroxyprogesterone. The defective enzyme is:
- (a) Aromatase
- (b) 21-hydroxylase
- (c) 5α-reductase
- (d) 17α-hydroxylase
Answer and explanation
(b) 21-hydroxylase. Loss of cortisol and aldosterone synthesis (salt wasting) with accumulation of 17-OH-progesterone and shunting to adrenal androgens (virilisation). 17α-hydroxylase deficiency would cause hypertension and lack of sex steroids instead.
Q4 (practice). Which drug action would increase insulin secretion from β cells?
- (a) Opening K_ATP channels
- (b) Blocking L-type Ca²⁺ channels
- (c) Binding SUR1 and closing K_ATP channels
- (d) Activating α₂-adrenergic receptors
Answer and explanation
(c). Closing K_ATP depolarises the β cell, opening Ca²⁺ channels and triggering exocytosis (sulfonylureas). Opening K_ATP (diazoxide), blocking Ca²⁺ entry or α₂ activation (Gi) all reduce secretion.
Level 3: Part C Style
Q1 (practice). Binding of a radiolabelled hormone to a membrane preparation gave the following Scatchard data (B = bound hormone in pmol per mg protein; F = free hormone in nM).
| B (pmol/mg) | B/F (pmol mg⁻¹ nM⁻¹) |
|---|---|
| 2 | 0.8 |
| 6 | 0.4 |
(i) Calculate Kd and Bmax assuming a single class of sites. (ii) What free hormone concentration gives half-maximal occupancy? (iii) A curved (concave-up) Scatchard plot is obtained with a different tissue. Give two explanations.
Answer and worked solution
- Scatchard: B/F = (Bmax − B)/Kd, so the slope = −1/Kd. Slope = (0.4 − 0.8)/(6 − 2) = −0.1 nM⁻¹ → Kd = 10 nM. Intercept: 0.8 = (Bmax − 2)/10 → Bmax = 10 pmol/mg. Check: (10 − 6)/10 = 0.4. Consistent.
- Half-maximal occupancy occurs at F = Kd = 10 nM (B = 5 pmol/mg; B/F = 0.5).
- Two or more classes of sites with different affinities, or negative cooperativity between sites (as reported for the insulin receptor). Non-specific binding not subtracted can also distort the plot.
Q2 (practice). Plasma hormone profiles were measured daily in a woman with regular 28-day cycles. Which statements are correct?
(A) A sharp rise in LH around day 14 follows several days of rising estradiol. (B) Progesterone is highest in the second half of the cycle. (C) FSH is suppressed in the mid-luteal phase by estradiol, progesterone and inhibin A. (D) Giving luteal-phase levels of progesterone throughout the follicular phase (from day 1) would make the LH surge larger.
- (a) A, B and C only
- (b) A and D only
- (c) B, C and D only
- (d) A, B, C and D
Answer and worked solution
(a) A, B and C only.
- (A) Sustained high estradiol switches the hypothalamic–pituitary response to positive feedback → LH surge. Correct.
- (B) The corpus luteum makes progesterone in the luteal phase. Correct.
- (C) Luteal steroids and inhibin A suppress gonadotropins; their fall at luteolysis lets FSH rise for the next cycle. Correct.
- (D) Wrong. Sustained progesterone during the follicular phase suppresses GnRH pulse frequency and blocks the surge (the basis of progestin-containing contraceptives).
Q3 (practice). In an insect experiment: (1) corpora allata are removed from a third-instar larva; (2) corpora allata from young larvae are implanted into a final-instar larva; (3) early in the final instar a larva is ligated between head and thorax; the part behind the ligature, which contains the prothoracic glands, never pupates unless ecdysone is injected.
Which conclusions are correct?
(A) Experiment 1 gives a precocious pupal or adult moult. (B) Experiment 2 gives an extra larval moult. (C) Experiment 3 shows that the brain’s signal (PTTH) is needed to trigger ecdysone secretion, and that ecdysone is the moulting hormone. (D) Juvenile hormone by itself triggers moulting.
- (a) A, B and C only
- (b) A and D only
- (c) C and D only
- (d) A, B, C and D
Answer and worked solution
(a) A, B and C only.
- (A) Without JH the next ecdysone pulse produces metamorphosis early. Correct.
- (B) Extra JH in the final instar keeps the “status quo”: another larval moult (a giant larva). Correct.
- (C) The ligature cuts the prothoracic glands off from the brain’s PTTH, so they secrete no ecdysone; injected ecdysone bypasses the block and the body pupates. So the brain signal acts upstream, and ecdysone is the moulting hormone. (A ligature tied later, after PTTH has been released, no longer prevents pupation.) Correct.
- (D) Wrong. JH determines the type of moult; ecdysone triggers moulting.
Quick Revision Table
| Item | Fact |
|---|---|
| Gs hormones | Glucagon, ACTH, TSH, LH, FSH, PTH, ADH-V₂, β |
| Gq hormones | GnRH, TRH, oxytocin, ADH-V₁, angiotensin II, α₁ |
| JAK–STAT | GH, prolactin, leptin, EPO |
| RTK | Insulin, IGF-1 |
| Nuclear | Steroids, T₃, calcitriol, retinoids |
| Hypothalamic hormones | TRH, CRH, GnRH, GHRH, somatostatin, dopamine |
| Posterior pituitary | ADH, oxytocin (made in SON/PVN) |
| Pineal | SCN → SCG → NE β₁ → AANAT → melatonin at night |
| Insects | PTTH → prothoracic gland → ecdysone; corpora allata → JH |
| Crustaceans | X-organ–sinus gland MIH inhibits Y-organ |
| GH | Pulsatile; IGF-1; diabetogenic |
| Thyroid | NIS, pendrin, TPO; T₄ secreted, T₃ active; deiodinases |
| Calcium | PTH (Ca ↑, P ↓), calcitriol (both ↑), calcitonin (Ca ↓), FGF23 (P ↓) |
| Adrenal cortex | Glomerulosa aldosterone; fasciculata cortisol; reticularis androgens |
| Steroidogenesis | StAR, CYP11A1 rate-limiting; 21-OH deficiency → CAH |
| Medulla | TH rate-limiting; PNMT (cortisol-induced) |
| β cell | Glucokinase → ATP → K_ATP closes → Ca²⁺ → insulin |
| C-peptide | Marker of endogenous insulin |
| Testis | Leydig LH testosterone; Sertoli FSH inhibin B ABP AMH |
| Ovary | Theca LH androgens; granulosa FSH aromatase estradiol |
| Cycle | Estradiol positive feedback → LH surge → ovulation; luteal progesterone |
| Oocyte arrests | Prophase I (diplotene) until ovulation; metaphase II until fertilisation |
| Pregnancy | hCG rescues corpus luteum; placenta takes over; estriol via fetoplacental unit |
| Lactation | Prolactin synthesis; oxytocin ejection |
| Sex differentiation | SRY → testis; AMH regresses Müllerian; DHT external genitalia |
Key Takeaways
What’s Next
- Gut Microbiome, Interorgan Communication and Metabolic Disorders — insulin, glucagon, adipokines and gut signals working across organs; diabetes and obesity.
- Basic Concepts of Development — gametogenesis and fertilisation from the developmental side.
- Regulation of Gene Expression and Epigenetics — nuclear receptors as transcription factors.
- Quick Revision — the whole unit on one page.